Night shift work and the risk of endometrial cancer

Cancer Research

Volumn 67, Issue 21, 2007, Pages 10618-10622

  Viswanathan, Akila N ^a   Hankinson, Susan E ^a,b   Schernhammer, Eva S ^a,b,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c KFJ Hospital   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; AROMATASE INHIBITOR; ESTRADIOL; MELATONIN;

ADULT; ARTICLE; BODY MASS; CANCER INVASION; CANCER PREVENTION; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; ENDOMETRIUM CANCER; ENZYME ACTIVITY; ENZYME INHIBITION; ESTROGEN ACTIVITY; FEMALE; HORMONE DETERMINATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPID METABOLISM; MAJOR CLINICAL STUDY; MEDICAL RECORD; METABOLIC REGULATION; NIGHT WORK; OBESITY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RECALL; RISK ASSESSMENT; SELF REPORT; SHIFT WORKER; STATISTICAL SIGNIFICANCE;

ADULT; BODY MASS INDEX; COHORT STUDIES; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MELATONIN; MIDDLE AGED; OBESITY; PROSPECTIVE STUDIES; RISK; WORK SCHEDULE TOLERANCE;

EID: 35948965596     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-07-2485     Document Type: Article

References (30)

1. Cancer facts and figures, 2007. (Accessed February, 2007, at http://www.cancer.org/docroot/STT/stt_0.asp).
2. Kaaks R, Lukanova A, Kurzer MS. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev 2002;11:1531-43.
3. Megdal SP, Kroenke CH, Laden F, Pukkala E, Schernhammer ES. Night work and breast cancer risk: a systematic review and meta-analysis. Eur J Cancer 2005;41:2023-32.
4. Schernhammer ES, Laden F, Speizer FE, et al. Night-shift work and risk of colorectal cancer in the nurses' health study. J Natl Cancer Inst 2003;95:825-8.
5. Kubo T, Ozasa K, Mikami K, et al. Prospective cohort study of the risk of prostate cancer among rotating-shift workers: findings from the Japan collaborative cohort study. Am J Epidemiol 2006;164:549-55.
6. Schernhammer E, Schulmeister K. Light at night and cancer risk. Photochem Photobiol 2004;79:316-8.
7. Stevens RG. Electric power use and breast cancer: a hypothesis. Am J Epidemiol 1987;125:556-61.
8. Cos S, Martinez-Campa C, Mediavilla MD, Sanchez-Barcelo EJ. Melatonin modulates aromatase activity in MCF-7 human breast cancer cells. J Pineal Res 2005;38:136-42.
9. Hussein MR, Ahmed OG, Hassan AF, Ahmed MA. Intake of melatonin is associated with amelioration of physiological changes, both metabolic and morphological pathologies associated with obesity: an animal model. Int J Exp Pathol 2007;88:19-29.
10. Raskind MA, Burke BL, Crites NJ, Tapp AM, Rasmussen DD. Olanzapine-induced weight gain and increased visceral adiposity is blocked by melatonin replacement therapy in rats. Neuropsychopharmacology 2007;32:284-8.
11. Alonso-Vale MI, Borges-Silva CN, Anhe GF, et al. Light/dark cycle-dependent metabolic changes in adipose tissue of pinealectomized rats. Horm Metab Res 2004;36:474-9.
12. Nachtigal MC, Patterson RE, Stratton KL, Adams LA, Shattuck AL, White E. Dietary supplements and weight control in a middle-age population. J Altern Complement Med 2005;11:909-15.
13. Grin W, Grunberger W. A significant correlation between melatonin deficiency and endometrial cancer. Gynecol Obstet Invest 1998;45:62-5.
14. Karasek M, Kowalski AJ, Zylinska K. Serum melatonin circadian profile in women suffering from the genital tract cancers. Neuroendocrinol Lett 2000;21:109-13.
15. Kanishi Y, Kobayashi Y, Noda S, Ishizuka B, Saito K. Differential growth inhibitory effect of melatonin on two endometrial cancer cell lines. J Pineal Res 2000;28:227-33.
16. Kobayashi Y, Itoh MT, Kondo H, et al. Melatonin binding sites in estrogen receptor-positive cells derived from human endometrial cancer. J Pineal Res 2003;35:71-4.
17. Colditz GA, Manson JE, Hankinson SE. The Nurses' Health Study: 20-year contribution to the understanding of health among women. J Womens Health 1997;6:49-62.
18. Burch JB, Yost MG, Johnson W, Allen E. Melatonin, sleep, and shift work adaptation. J Occup Environ Med 2005;47:893-901.
19. Sainz RM, Mayo JC, Rodriguez C, Tan DX, Lopez-Burillo S, Reiter RJ. Melatonin and cell death: differential actions on apoptosis in normal and cancer cells. Cell Mol Life Sci 2003;60:1407-26.
20. Blask DE, Sauer LA, Dauchy RT. Melatonin as a chronobiotic/anticancer agent: cellular, biochemical, and molecular mechanisms of action and their implications for circadian-based cancer therapy. Curr Trop Med Chem 2002;2:113-32.
21. Lissoni P, Rovelli F, Malugani F, Bucovec R, Conti A, Maestroni GJ. Anti-angiogenic activity of melatonin in advanced cancer patients. Neuro Endocrinol Lett 2001;22:45-7.
22. Vijayalaxmi, Thomas CRJ, Reiter RJ, Herman TS. Melatonin: from basic research to cancer treatment clinics. J Clin Oncol 2002;20:2575-601.
23. del Rio B, Garcia Pedrero JM, Martinez-Campa C, Zuazua P, Lazo PSR, S. Melatonin, an endogenous-specific inhibitor of estrogen receptor α via calmodulin. J Biol Chem 2004;279:38294-302.
24. Cos S, Gonzalez A, Guezmes A, et al. Melatonin inhibits the growth of DMBA-induced mammary tumors by decreasing the local biosynthesis of estrogens through the modulation of aromatase activity. Int J Cancer 2006;118:274-8.
25. Schernhammer ES, Rosner B, Willett WC, Laden F, Colditz GA, Hankinson SE. Epidemiology of urinary melatonin in women and its relation to other hormones and night work. Cancer Epidemiol Biomarkers Prev 2004;13:936-43.
26. Barrenetxe J, Delagrange P, Martinez JA. Physiological and metabolic functions of melatonin. J Physiol Biochem 2004;60:61-72.
27. Delagrange P, Atkinson J, Boutin JA, et al. Therapeutic perspectives for melatonin agonists and antagonists. J Neuroendocrinol 2003;15:442-8.
28. Karlsson B, Knutsson A, Lindahl B. Is there an association between shift work and having a metabolic syndrome? Results from a population based study of 27,485 people. Occup Environ Med 2001;58:747-52.
29. Alonso-Vale MI, Andreotti S, Peres SB, et al. Melatonin enhances leptin expression by rat adipocytes in the presence of insulin. Am J Physiol Endocrinol Metab 2005;288:E805-12.
30. Adam CL, Mercer JG. Appetite regulation and seasonality: implications for obesity. Proc Nutr Soc 2004;63:413-9.